{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:34:02Z","timestamp":1780353242256,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12149-023-01876-3","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:10:09Z","timestamp":1699243809000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A prospective study of 68Ga-PSMA PET\/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-4285","authenticated-orcid":false,"given":"Shamim Ahmed","family":"Shamim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Jaswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand","family":"Gamanagatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"issue":"6","key":"1876_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","volume":"9","author":"MC Wallace","year":"2015","unstructured":"Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765\u201379.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"1876_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1665-2681(19)30859-2","volume":"13","author":"K O'Connor","year":"2014","unstructured":"O\u2019Connor K, Walsh JC, Schaeffer DF. Combined hepatocellular- cholangiocarcinoma (cHCC-CC): a distinct entity. Ann Hepatol. 2014;13(3):317\u201322.","journal-title":"Ann Hepatol"},{"issue":"2","key":"1876_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u201350.","journal-title":"Hepatology"},{"issue":"9828","key":"1876_CR4","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/S0140-6736(12)60358-4","volume":"379","author":"R Dikshit","year":"2012","unstructured":"Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al. Cancer mortality in India: a nationally representative survey. Lancet. 2012;379(9828):1790.","journal-title":"Lancet"},{"issue":"6","key":"1876_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1046\/j.1440-1746.2001.02476.x","volume":"16","author":"SK Sarin","year":"2001","unstructured":"Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16(6):666\u201373.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3\u20134","key":"1876_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000231886","volume":"77","author":"SB Paul","year":"2009","unstructured":"Paul SB, Chalamalasetty SB, Vishnubhatla S, Madan K, Gamanagatti SR, Batra Y, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77(3\u20134):162\u201371.","journal-title":"Oncology"},{"issue":"8","key":"1876_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/BF01297461","volume":"36","author":"R Naccarato","year":"1991","unstructured":"Naccarato R, Farinati F. Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses. Dig Dis Sci. 1991;36(8):1137\u201342.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1876_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gut.2004.052167","volume":"54","author":"JA Davila","year":"2005","unstructured":"Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54(4):533\u20139.","journal-title":"Gut"},{"issue":"1","key":"1876_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121(1):91\u2013100.","journal-title":"Gastroenterology"},{"issue":"11","key":"1876_CR10","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321 (Erratum in: Cancer Res. 2014;74(14):4006).","journal-title":"Cancer Res"},{"key":"1876_CR11","first-page":"1408","volume":"3","author":"KS Chhonker","year":"2018","unstructured":"Chhonker KS, Rawat D, Naik RA, Koiri RK. An overview of mycotoxins in human health with emphasis on development and progression of liver cancer. Clin Oncol. 2018;3:1408.","journal-title":"Clin Oncol"},{"key":"1876_CR12","doi-asserted-by":"crossref","unstructured":"Dhanasekaran R, Bandoh S, Roberts LR. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Res. 2016;5:F1000 Faculty Rev-879.","DOI":"10.12688\/f1000research.6946.1"},{"issue":"12","key":"1876_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.4254\/wjh.v7.i12.1632","volume":"7","author":"MH Attwa","year":"2015","unstructured":"Attwa MH, El-Etreby SA. Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol. 2015;7(12):1632\u201351.","journal-title":"World J Hepatol"},{"issue":"8","key":"1876_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11604-020-00961-1","volume":"38","author":"K Ozaki","year":"2020","unstructured":"Ozaki K, Harada K, Terayama N, Kosaka N, Kimura H, Gabata T. FDG-PET\/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn J Radiol. 2020;38(8):697\u2013718.","journal-title":"Jpn J Radiol"},{"issue":"5","key":"1876_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.acuro.2021.01.004","volume":"45","author":"PJ Plaza L\u00f3pez","year":"2021","unstructured":"Plaza L\u00f3pez PJ, Puertas E, Aguil\u00f3 JJ, Suarez-Pi\u00f1era M, Domenech B, Mestre-Fusco A, et al. 68Ga-PSMA-11 PET\/CT in patients with occult biochemical recurrence of prostate carcinoma and negative 18F-Choline PET\/CT. Preliminary assessment of its clinical use. Actas Urol Esp (Engl Ed). 2021;45(5):353\u20138.","journal-title":"Actas Urol Esp (Engl Ed)."},{"issue":"12","key":"1876_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","volume":"40","author":"MC Haffner","year":"2009","unstructured":"Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, M\u00fchlmann G, et al. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol. 2009;40(12):1754\u201361.","journal-title":"Hum Pathol"},{"issue":"2","key":"1876_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2967\/jnumed.118.214833","volume":"60","author":"M Kesler","year":"2019","unstructured":"Kesler M, Levine C, Hershkovitz D, Mishani E, Menachem Y, Lerman H, et al. 68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: a prospective pilot study. J Nucl Med. 2019;60(2):185\u201391.","journal-title":"J Nucl Med"},{"issue":"2","key":"1876_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/wjnm.WJNM_11_17","volume":"17","author":"HL Huang","year":"2018","unstructured":"Huang HL, Zhen Loh TJ, Hoe Chow PK. A case of well-differentiated hepatocellular carcinoma identified on gallium-68prostate-specific membrane antigen positron emission tomography\/computed tomography. World J Nucl Med. 2018;17(2):102\u20135.","journal-title":"World J Nucl Med."},{"issue":"1","key":"1876_CR19","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/RLU.0000000000001355","volume":"42","author":"S Taneja","year":"2017","unstructured":"Taneja S, Taneja R, Kashyap V, Jha A, Jena A. 68Ga-PSMA uptake in hepatocellular carcinoma. Clin Nucl Med. 2017;42(1):e69\u201370.","journal-title":"Clin Nucl Med"},{"key":"1876_CR20","first-page":"1091","volume":"1","author":"C Soydal","year":"2016","unstructured":"Soydal C, Alkan A, Ozkan E, Demirkaz\u0131k A, Kucuk NO. Ga-68 PSMA accumulation in hepatocellular carcinoma. Clin Oncol. 2016;1:1091.","journal-title":"Clin Oncol"},{"issue":"1","key":"1876_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","volume":"20","author":"BF de Galiza","year":"2020","unstructured":"de Galiza BF, Queiroz MA, Nunes RF, Costa LB, Zaniboni EC, Marin JFG, et al. Non-prostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020;20(1):23.","journal-title":"Cancer Imaging"},{"issue":"5","key":"1876_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","volume":"10","author":"D Jiao","year":"2019","unstructured":"Jiao D, Li Y, Yang F, Han D, Wu J, Shi S, et al. Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(5):1\u20137.","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"1876_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep4.1861","volume":"6","author":"SM Thompson","year":"2022","unstructured":"Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, et al. PSMA as a theranostic target in hepatocellular carcinoma: immunohistochemistry and 68Ga-PSMA-11 PET using cyclotron-produced 68Ga. Hepatol Commun. 2022;6(5):1172\u201385.","journal-title":"Hepatol Commun"},{"issue":"9","key":"1876_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2967\/jnumed.120.257915","volume":"62","author":"N Hirmas","year":"2021","unstructured":"Hirmas N, Leyh C, Sraieb M, Barbato F, Schaarschmidt BM, Umutlu L, et al. 68Ga-PSMA-11 PET\/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma. J Nucl Med. 2021;62(9):1235\u201341.","journal-title":"J Nucl Med"},{"issue":"1","key":"1876_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13000-020-00982-4","volume":"15","author":"W Chen","year":"2020","unstructured":"Chen W, Lee Z, Awadallah A, Zhou L, Xin W. Peritumoral\/vascular expression of PSMA as a diagnostic marker in hepatic lesions. Diagn Pathol. 2020;15(1):92.","journal-title":"Diagn Pathol"},{"issue":"3","key":"1876_CR26","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1097\/RLU.0000000000002452","volume":"44","author":"PM Perez","year":"2019","unstructured":"Perez PM, Flavell RR, Kelley RK, Umetsu S, Behr SC. Heterogeneous uptake of 18F-FDG and 68Ga-PSMA-11 in hepatocellular carcinoma. Clin Nucl Med. 2019;44(3):e133\u20135.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"1876_CR27","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00259-023-06155-x","volume":"50","author":"Q Lu","year":"2023","unstructured":"Lu Q, Long Y, Gai Y, Liu Q, Jiang D, Lan X. [177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy. Eur J Nucl Med Mol Imaging. 2023;50(8):2342\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01876-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-023-01876-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01876-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T16:09:55Z","timestamp":1706717395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-023-01876-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1876"],"URL":"https:\/\/doi.org\/10.1007\/s12149-023-01876-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}